Male gender as a favorable prognostic factor in pregnancies with enlarged nuchal translucency

Ultrasound in Obstetrics and Gynecology

Volumn 34, Issue 4, 2009, Pages 373-378

  Timmerman, E ^a   Pajkrt, E ^a   Bilardo, C M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Fetal gender; Nuchal translucency; Pregnancy outcome; Y chromosome

Indexed keywords

ARTICLE; CHROMOSOME ABERRATION; CROWN RUMP LENGTH; FEMALE; FETUS; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GENDER; HUMAN; KARYOTYPING; MAJOR CLINICAL STUDY; MALE; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY OUTCOME; PRIORITY JOURNAL;

ADOLESCENT; ADULT; FEMALE; FETAL VIABILITY; HUMANS; INFANT, NEWBORN; KARYOTYPING; MALE; NUCHAL TRANSLUCENCY MEASUREMENT; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY OUTCOME; PROGNOSIS; RISK FACTORS; SEX FACTORS; YOUNG ADULT;

EID: 70350212416     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.6397     Document Type: Article

References (29)

1. Spencer K, Ong CY, Liao AW, Papademetriou D, Nicolaides KH. The influence of fetal sex in screening for trisomy 21 by fetal nuchal translucency, maternal serum free beta-hCG and PAPP-A at 10-14 weeks of gestation. Prenat Diagn 2000; 20: 673-675. (Pubitemid 30598916)
2. De Graaf I, Cuckle HS, Pajkrt E, Leschot NJ, Bleker OP, van Lith JM. Co-variables in first trimester maternal serum screening. Prenat Diagn 2000; 20: 186-189. (Pubitemid 30168823)
3. Yaron Y, Wolman I, Kupferminc MJ, Ochshorn Y, Many A, Orr-Urtreger A. Effect of fetal gender on first trimester markers and on Down syndrome screening. Prenat Diagn 2001; 21: 1027-1030. (Pubitemid 34056184)
4. Lam YH, Tang MH, Lee CP, Sin SY, Tang R, Wong HS, Wong SF. The effect of fetal gender on nuchal translucency at 10-14 weeks of gestation. Prenat Diagn 2001; 21: 627-629. (Pubitemid 32843917)
5. Larsen SO, Wøjdemann KR, Shalmi AC, Sundberg K, Christiansen M, Tabor A. Gender impact on first trimestermarkers in Down syndrome screening. Prenat Diagn 2002; 22: 1207-1208. (Pubitemid 36043170)
6. Prefumo F, Venturini PL, De Biasio P. Effect of fetal gender on first-trimester ductus venosus blood flow. Ultrasound Obstet Gynecol 2003; 22: 268-270. (Pubitemid 37088551)
7. http://www.fetalmedicine.com [accessed 14 July 2008].
8. Van der Pal-de Bruin KM, Verloove-Vanhorick SP, Roeleveld N. Change in male : female ratio among newborn babies in Netherlands. Lancet 1997; 349: 62. (Pubitemid 27023012)
9. Hassold T, Quillen SD, Yamane JA. Sex ratio in spontaneous abortions. Ann Hum Genet 1983; 47: Pt 1 39-47.
10. Eiben B, Bartels I, Bähr-Porsch S, Borgmann S, Gatz G, Gellert G, Goebel R, Hammans W, Hentemann M, Osmers R, Rauskolb R, Hansmann I. Cytogenetic analysis of 750 spontaneous abortions with the direct-preparation method of chorionic villi and its implications for studying genetic causes of pregnancy wastage. Am J Hum Genet 1990; 47: 656-663. (Pubitemid 20356946)
11. Pajkrt E, Chitty LS. Prenatal gender determination and the diagnosis of genital anomalies. BJU Int 2004; 93 (Suppl 3): 12-19. (Pubitemid 38580909)
12. Borrell A, Antolin E, Costa D, Farre MT, Martinez JM, Fortuny A. Abnormal ductus venosus blood flow in trisomy 21 fetuses during early pregnancy. Am J Obstet Gynecol 1998; 179: 6 Pt 1 1612-1617. (Pubitemid 29028410)
13. Matias A, Gomes C, Flack N, Montenegro N, Nicolaides KH. Screening for chromosomal abnormalities at 10-14 weeks: the role of ductus venosus blood flow. Ultrasound Obstet Gynecol 1998; 12: 380-384. (Pubitemid 29034205)
14. Antolin E, Comas C, Torrents M, Muñoz A, Figueras F, Echevarría M, Cararach M, Carrera JM. The role of ductus venosus blood flow assessment in screening for chromosomal abnormalities at 10-16 weeks of gestation. Ultrasound Obstet Gynecol 2001; 17: 295-300. (Pubitemid 32417442)
15. Bilardo CM, M̈uller MA, Zikulnig L, Schipper M, Hecher K. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome. Ultrasound Obstet Gynecol 2001; 17: 288-294. (Pubitemid 32417441)
16. Montenegro N, Matias A, Areias JC, Castedo S, Barros H. Increased fetal nuchal translucency: possible involvement of early cardiac failure. Ultrasound Obstet Gynecol 1997; 10: 265-268. (Pubitemid 27485323)
17. Brand-Saberi B, Epperlein HH, Romanos GE, Christ B. Distribution of extracellular matrix components in nuchal skin from fetuses carrying trisomy 18 and trisomy 21. Cell Tissue Res 1994; 277: 465-475. (Pubitemid 24267512)
18. Brand-Saberi B, Flöel H, Christ B, Schulte-Vallentin M, Schindler H. Alterations of the fetal extracellular matrix in the nuchal oedema of Down's syndrome. Ann Anat 1994; 176: 539-547. (Pubitemid 24368870)
19. Von Kaisenberg CS, Brand-Saberi B, Christ B, Vallian S, Farzaneh F, Nicolaides KH. Collagen type VI gene expression in the skin of trisomy 21 fetuses. Obstet Gynecol 1998; 91: 319-323. (Pubitemid 28119828)
20. Von Kaisenberg CS, Krenn V, Ludwig M, Nicolaides KH, Brand-Saberi B. Morphological classification of nuchal skin in human fetuses with trisomy 21, 18, and 13 at 12-18 weeks and in a trisomy 16 mouse. Anat Embryol (Berl) 1998; 197: 105-124. (Pubitemid 28083408)
21. Haak MC, Bartelings MM, Jackson DG, Webb S, van Vugt JM, Gittenberger-de Groot AC. Increased nuchal translucency is associated with jugular lymphatic distension. Hum Reprod 2002; 17: 1086-1092. (Pubitemid 34411150)
22. Bekker MN, Twisk JW, Bartelings MM, Gittenberger-de Groot AC, van Vugt JM. Temporal relationship between increased nuchal translucency and enlarged jugular lymphatic sac. Obstet Gynecol 2006; 108: 846-853.
23. de Zegher F, Francois I, Boehmer AL, Saggese G, Müller J, Hiort O, Sultan C, Clayton P, Brauner R, Cacciari E, Ibáñez L, Van Vliet G, Tiulpakov A, Saka N, Ritzẽn M, Sippell WG. Androgens and fetal growth. Horm Res 1998; 50: 243-244.
24. Huggon IC, Turan O, Allan LD. Doppler assessment of cardiac function at 11-14 weeks' gestation in fetuses with normal and increased nuchal translucency. Ultrasound Obstet Gynecol 2004; 24: 390-398. (Pubitemid 39179473)
25. Clur SA, Ottenkamp J, Bilardo CM. OP18.06. Increased fetal nuchal translucency and cardiac (dys)function. Ultrasound Obstet Gynecol 2007; 30: 517.
26. Di Renzo GC, Rosati A, Sarti RD, Cruciani L, Cutuli AM. Does fetal sex affect pregnancy outcome? Gend Med 2007; 4: 19-30. (Pubitemid 46917064)
27. Sheiner E, Levy A, Katz M, Hershkovitz R, Leron E, Mazor M. Gender does matter in perinatal medicine. Fetal Diagn Ther 2004; 19: 366-369. (Pubitemid 38822759)
28. Mutton D, Alberman E, Hook EB. Cytogenetic and epidemiological findings in Down syndrome, England and Wales 1989 to 1993. National Down Syndrome Cytogenetic Register and the Association of Clinical Cytogeneticists. J Med Genet 1996; 33: 387-394.
29. Bilardo CM, Müller MA, Pajkrt E, Clur SA, van Zalen MM, Bijlsma EK. Increased nuchal translucency thickness and normal karyotype: time for parental reassurance. Ultrasound Obstet Gynecol 2007; 30: 11-18. (Pubitemid 47074846)